They are show casing our GBM drug at a conference in June.
We haven't seen any results from the 3rd cohort yet.
Maybe a long stretch to join these two, but the city of hope just gave ethics approval for the expansion trial. The drug has been developed and trialed by them. They would have good insight into how it would be performing.
Lots of end of financial year selling to go. But will be interesting to see what is said at the conference.
CHM Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)